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In late fall of 1994, Lorain County, Ohio,
became the site of the first investigation of
several large-scale incidences in which the pes-
ticide methyl parathion was illegally applied to
private residences. Public health authorities
became aware of the contamination when a
homeowner contacted the Ohio Department
of Agriculture regarding a chemical odor that
had persisted for weeks following commercial
pesticide application in his home. Surface
wipe sampling in the home identiﬁed methyl
parathion. County authorities visited the
applicator’s home and conﬁscated containers
of methyl parathion that had been purchased
at an undisclosed location in another state.
The applicator reported that he had been
applying this product in hundreds of Lorain
County residences over the course of the pre-
vious 5–7 years. The applicator did not main-
tain a record of client addresses, dates,
volume, or strength of pesticide applied, or
protocol for application. The extent of poten-
tial human exposure to this pesticide led the
Ohio Department of Health to formally
request technical assistance from the Centers
for Disease Control and Prevention (CDC)
(1). In January 1995 the U.S. Environmental
Protection Agency (U.S. EPA) declared
methyl parathion–contaminated homes in
Lorain County, Ohio, a Superfund cleanup
site. During the 2-year evaluation and remedi-
ation of these homes, the CDC, in collabora-
tion with county and city health officials,
conducted a study of organophosphate (OP)
pesticide exposure and adverse health effects
among residents in Lorain County, Ohio,
who lived in homes where methyl parathion
had been inappropriately sprayed.
Methyl parathion is an OP pesticide
intended for outdoor use only and is classiﬁed
in U.S. EPA Toxicity Category I (i.e., most
toxic). OP pesticide poisoning occurs when
humans are exposed, either intentionally or
unintentionally, to this class of pesticide.
Although the literature reports several case
examples of misuse of OP pesticides (2), the
route of exposure is usually oral rather than
dermal or inhalation (3). Very little is known
about unintentional nonoccupational expo-
sure, especially in children. The circumstances
of methyl parathion misuse in Lorain County
may be considered a unique natural experi-
ment. This incident provided the public
health community with an opportunity to fur-
ther define human exposure as well as acute
and short-term health effects associated with
exposure. We conducted a study in Lorain
County, Ohio, during the Superfund cleanup
period to chronicle adverse health events that
occurred during the postspray period.
Methods
A few potentially contaminated homes were
identiﬁed by reviewing limited notes found in
the applicator’s home, but the majority of the
potentially contaminated sites were identiﬁed
through self-report from residents to local
health officials. The residents were asked to
recall approximate month(s) that the applica-
tor had applied the pesticide and to also
report what locations in the home had been
sprayed. Although the primary reason for
application in most homes was roach infesta-
tion, a common application pattern was not
apparent. Many residents responded that they
were told by landlords or neighbors that their
home had been sprayed prior to their occu-
pancy. The U.S. EPA assigned a level of
remediation to the more than 500 single- and
multiple-dwelling structures (4) and priori-
tized the timing of evacuation or cleaning
based on the results of environmental and
biological sampling. All homes that the 
U.S. EPA designated as requiring priority
level I or II cleaning were visited and invited
to participate in our study prior to evacuation
or cleaning. Once informed consent was
obtained, we set up an appointment time for
a motor home that had been rented for the
study to park outside the home and serve as
the site for questionnaire administration and
urine sample collection.
We administered household questionnaires
to adults who self-identified as head of the
household. We collected demographic infor-
mation for everyone who lived in the home,
the approximate amount of time that each per-
son had spent in the home since the spray
date, the spray pattern used in the home, and
the use of any product that the applicator may
have left behind. In addition, we used the
household questionnaire to ﬁnd out if anyone
living in the home or any pets kept in the
home had been hospitalized or died since the
last spray date. Because of the potential size of
the study population and because we were
conducting interviews during a time when
homes were being evacuated, we did not try to
collect individual questionnaire information
from every resident. We did obtain individual
questionnaire information for each person who
completed a household questionnaire. The
remaining individual questionnaires were
completed by residents who were available and
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willing to participate at the initial interview
date. During the individual interview we asked
about 23 physical symptoms, including those
consistent with pesticide exposure (e.g., severe
or frequent headaches, dizziness, sensitivity to
light, nausea, vomiting) as well as several signs
or symptoms not traditionally associated with
OP exposure (e.g., fever, dental discomfort)
experienced during the two weeks following
methyl parathion application. We asked if
these symptoms were still present and whether
they improved when the participant was out of
the home. All available participants were asked
to provide a convenience urine sample.
Upon completion of the survey, we used
the household questionnaire to identify 63
homes where the respondent answered yes to
the question “Since the last spraying, has any-
one in your home been hospitalized?” (n =
59), or to the question “Since the last spray-
ing, has anyone in your home died?” (n = 9).
Five homes reported both hospitalization and
death. We visited each eligible home and
invited residents to participate in an extended
open-ended interview session and to provide
consent for us to obtain medical records.
After excluding hospitalizations for child-
birth, chronic disease rehospitalizations, and
geriatric deaths associated with preexisting
chronic disease, we reviewed the medical
records of 49 people. We recorded the pre-
senting signs and symptoms, physical exami-
nation ﬁndings, vital signs, laboratory results,
and discharge diagnosis for each patient visit
to a health care provider. We developed a set
of criteria for excluding or including a person
as a potential case of organophosphate poi-
soning. We excluded anyone whose medical
records suggested a primary diagnosis of
trauma or who had a well-documented infec-
tious disease diagnosis. For example, we
excluded cases with any notation of a positive
blood, sputum, or urine culture, or abnormal
otoscopic exam. We also excluded cases with
diagnosed abnormal imaging of the chest
(e.g., pneumonia), abdomen, or head (e.g.,
tumor), or a gynecologic or psychiatric diag-
nosis. Among the remaining medical records,
we considered those describing gastrointesti-
nal complaints (e.g., abdominal pain or
cramping, vomiting, or diarrhea), central ner-
vous system (e.g., dizziness, headache) symp-
toms, respiratory symptoms (e.g., wheezing,
shortness of breath), or evidence of increased
secretions (e.g., excessive lacrimation or
sweating) as being most likely to be potential
cases of OP poisoning.
Of 289 homes eligible for participation,
254 (87.9%) provided complete household
questionnaire information. We collected
individual questionnaire information from
747 of the 1,095 people living in the partici-
pating homes, and collected at least one
urine sample from 776 of the residents.
Overall, 626 participants had complete
household and individual questionnaire
information and also had provided sufﬁcient
urine to analyze for p-nitrophenol (PNP, a
metabolite of methyl parathion) and creati-
nine (5). Reference range PNP values (range
0–63 ppb, mean 1.6 ppb, median < 1.0 ppb,
99th percentile 16 ppb) had previously been
reported from the CDC laboratory using cre-
atinine-adjusted urine samples collected dur-
ing the Third National Health and Nutrition
Examination Survey (NHANES) (6). We
used only creatinine-adjusted urinary PNP
concentration in our statistical analysis. All
descriptive statistics including means, medi-
ans, and frequencies were calculated using
SAS software, Version 8 (7). Figures were
created using Microsoft Excel 2000.
Laboratory Analysis
PNP measurements were made using the
method of Hill et. al. (8). This highly speciﬁc
and accurate method involves the use of car-
bon 14–labeled PNP as an internal standard
(isotope dilution technique). After the addi-
tion of the internal standard, urine samples
were hydrolyzed with enzyme, extracted and
derivatized, and then analyzed using capillary
gas chromatography combined with tandem
mass spectrometry. A strict quality assurance
program ensured that the sample results were
reliable. This method was used with samples
from the NHANES to establish reference
range concentrations (9). Urinary creatinine
was determined using a Kodak 250
Analyzercolorimetric method with creatinine
kinase (10).
Results
Household Questionnaires
The 254 homes that we evaluated varied in
age, number of rooms, number of years the
current resident had lived in the home, and the
number of people currently living in the home.
Overall, these homes were older (median 25
years), of average size (median six rooms), and
exhibited typical occupancy (median four per-
sons living in the home). Transiency of this
population is suggested by a mean of 1 year of
residency for the current occupants. Almost
90% of the residences were rental units. The
1,095 people who lived in the 254 homes that
we evaluated ranged in age from 1 week to 83
years (median 14.5 years). Fifty-seven percent
of the residents were female and 68% were
non-Hispanic black. Participants 15 years of
age or younger were equally divided by gender;
among residents older than 16 years, two-
thirds were females and one-third were males.
Every household that we evaluated contributed
at least one individual questionnaire (range
1–14, median 3) and at least one urine sample
(range 1–10, median 2).
The household questionnaire ascertained
that at some point in the past, all of the
homes that we surveyed had been sprayed by
the applicator who used methyl parathion,
although he appeared to vary the application
pattern. Baseboards and cabinets beneath
sinks were consistently sprayed in most
homes; optional spray areas included heating
duct systems, children’s sleeping areas, and
outdoor areas. The residents in our study
population reported that they were
instructed by the applicator to stay out of
their house for several hours after spraying
(64%), stay away overnight (7%), and in
many instances (41%) they were told to
wash their dishes before using them. The
applicator left product in amounts ranging
from 1 to 64 cups at 12% of the homes.
Among those residents who had methyl
parathion left in their homes, 89% had
applied the product either as a spray or a
wipe.
Fifty-four (23%) of the homes reported
having at least one indoor pet. In response
to the question “Did you have a pet that
died within two weeks of your home being
sprayed?”, residents reported dogs, cats,
birds, and fish had died. Thirty-five of the
homes with indoor pets experienced an ani-
mal death. One resident anecdotally
reported that his dog slept on a carpet that
was still slightly damp from spraying that
had occurred the day before. The dog
became ill during the night with vomiting,
diarrhea, and ataxia, and his normally light-
colored fur was discolored to a yellowish-
green. The dog died en route to the
veterinarian. This animal, and at least two
others, were presumptively diagnosed as
having died from pesticide poisoning. No
laboratory tests were performed, and there is
no record that these incidents were reported
to the health department.
Individual Questionnaires
The 747 people who completed individual
questionnaires ranged in age from 1 week to
83 years (median 13.0). Parents or guardians
completed information for children less than
10 years of age. Respondents reported a vari-
ety of preexisting physician-diagnosed
chronic physical conditions, including
asthma (18%), migraine headaches (15%),
hypertension (10%), diabetes (4%), and
cancer (2%). When asked about signs and
symptoms that originated during the 2-week
period following methyl parathion spraying,
they reported headaches (30%), nausea
(29%), night waking (28%), diarrhea
(26%), restlessness (23%), difficulty breath-
ing (21%), dizziness (21%), abdominal
cramps (20%), excessive sweating (13%),
incoordination (11%), excess salivation
(9%), and mental confusion (7%).
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Urine Samples
The 626 people with complete household
and individual questionnaire information and
laboratory analysis for PNP level were similar
demographically to those participants without
PNP samples (Table 1). Although 213 (34%)
of these people did not specify an exact date
when their home was sprayed, 179 (29%)
reported that spraying had occurred within
the past 180 days, 116 (19%) reported spray-
ing between 180 and 365 days previously,
and the remaining 118 (19%) said their
home had been sprayed more than one year
before sample collection. People living in
homes sprayed <180 days previously were
most likely to have the highest PNP levels
(23% > 100 ppb PNP), but even people liv-
ing in homes sprayed more than a year previ-
ously appeared to be highly exposed (8% >
100 ppb PNP) (Figure 1). Among the 213
people who did not know the date when their
home was sprayed, 74% had no detectable
PNP, 16% were < 50 ppb, 7% were ≥50 to
100 ppb, and 3% were ≥100 ppb PNP.
Median PNP among the 28 study
participants < 3 years of age was 94 ppb,
compared with median 50 ppb among the 
≥3 to < 16 years of age group (n = 125),
median 31 ppb among the ≥16 to 46 years of
age group (n = 107), and 49 ppb among peo-
ple 46 years of age or older (n = 25). Age was
unknown for ﬁve people who had detectible
levels of PNP. A comparison of the age distri-
bution of the 626 people who participated in
urine sample analysis to the distribution of
urinary PNP by age group suggests that the
youngest and the oldest residents experienced
the greatest exposure to methyl parathion
sprayed in their homes (Figure 2).
Follow-up of Postspray
Hospitalizations and Deaths
Of the 49 residents we followed up because
they were hospitalized or died after their
home was sprayed, 26 were less than 17 years
of age. We summarized each case history and
presented them to a series of medical review-
ers who, guided by the criteria described in
“Methods,” classified 21 individuals as
potentially manifesting organophosphate
poisoning. Their ages ranged from 1 month
to 44 years, with 12 (57%) of them younger
than 3 years of age. Only one death was
reported that fit our criteria for potential
organophosphate poisoning. The number of
days between hospitalization and reported
spray date varied, including date unknown
(n = 2), <1 week (n = 3), >1 week but <3
months (n = 8), and ≥3 months but less than
1 year (n = 8). Six of the case study patients
had urinary PNP results available from the
household survey. Only two of the case sub-
jects had medical records that mentioned
possible toxic exposure, and in both instances
the reference specified potential misuse of
prescription or recreational drugs. Three of
the case studies are described below.
Case 1. On the day her house was
sprayed, a full-term, previously healthy girl 4
months of age became irritable and seemed
congested in her upper airway, with a thick
whitish nasal discharge. Over the next sev-
eral days these symptoms persisted, and she
began to refuse food, developed a fever,
more frequent bowel movements, and
decreased sleep. On day 6, she was brought
to the emergency department (ED) and was
given iv antibiotics, fluids, oxygen, and a
series of tests to determine infection status.
Results included the following abnormal ele-
vations: white blood cell (WBC) count,
18,700 (normal range, 4,800–10,800);
platelets, 873,000 (normal range,
150,000–400,000); sodium, 160 milliequiv-
alents per liter (MEQ/L) (normal range,
139–146); and chloride, 127 MEQ/L (nor-
mal range, 95–105). Chest and abdominal X
rays were normal. She was discharged with a
diagnosis of upper respiratory infection and
a prescription for an antibiotic.
That night the child’s condition worsened;
paramedics were called and she was trans-
ported by air ambulance to a pediatric inten-
sive care unit (PICU). Physical examination
revealed lethargy, moderate to severe dehydra-
tion, and heme-positive, black, foul-smelling
stools. Laboratory and X-ray tests were
repeated and were the same as reported by the
ED. All cultures (i.e., cerebrospinal fluid,
blood, urine, stool) were negative.
The patient was given a working diagnosis
of dehydration and hypernatremia. She
remained in the hospital for more than 
1 week, receiving fluids and antibiotics. She
was discharged home without medications,
but she continued to have a head lag.
Fourteen months later her home was evalu-
ated for methyl parathion contamination, and
her urinary PNP level was 89 ppb.
Case 2. A boy 18 months of age was
brought to the ED by his mother 3 days after
their home had been sprayed. The child had
been crying inconsolably for several hours
before he collapsed, becoming limp and difﬁ-
cult to arouse. He also had three apneic
episodes lasting 15–20 sec each, causing his
mother to apply mouth-to-mouth resuscita-
tion. No vomiting or diarrhea was reported.
In the ED the child was noted to be lethargic
but would cry in response to stimulation.
His temperature was 37.9°C (100.2°F),
pupil size and reactivity were normal, and
skin was warm and dry. Physical exam, X
rays, spinal tap, and laboratory tests were
normal with the exception of an elevated
WBC count of 11,400 (normal range
4,800–10,800). After the spinal tap, the
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Table 1. Demographic information from people with and without urine samples analyzed for PNP during
the investigation of health effects related to indoor application of methyl parathion in Lorain County, Ohio,
1995–1996.
All study residents Residents with urinary PNP Residents without urine results
(n = 1,095)a results (n = 626)b (n = 469)c
Age
Range < 1 year–83.0 years <1 year–83.0 years <1 year–82 years
Median 14.0 years 14.0 years 15.0 years
Sex (female) 600 (56%) 366 (59%) 234 (53%)
Race/ethnicity 706 (68%) 398 (65%) 308 (73%)
(non-Hispanic black)
aInformation on age missing for 38 people; information on race/ethnicity missing for 63 people; information on sex missing
for 30 people. bInformation on age missing for 8 people; information on race/ethnicity missing for 17 people; information on
sex missing for 4 people. cInformation on age missing for 30 people; information on race/ethnicity missing for 46 people;
information on sex missing for 26 people.
Days since spray category
P
e
r
c
e
n
t
a
g
e
60
50
40
30
20
10
0
35.7
29.6
11.7
22.9
45.7
28.4
13.8 12.1
52.5
31.4
7.6 8.5
< 180 180 to < 365 365+
ND
< 50 ppb
50 to < 100 ppb
100+ ppb
Figure 1: Percentage of people in each of four 
creatinine-adjusted PNP categories ranging from
nondetectable to > 100 ppb, according to the num-
ber of days since a home was sprayed with a
known spray for the 290 people who participated in
a study of health effects following indoor applica-
tion of methyl parathion in Lorain County, Ohio,
1995–1996. 
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Figure 2. The median PNP level within age cate-
gory of people who had complete questionnaire
information and detectable levels of urinary PNP
and participated in the investigation of health
effects that occurred after methyl parathion was
sprayed in Lorain County, Ohio, homes, 1995–1996.child had another apneic spell, became
hypertensive, tachycardic, and developed
pinpoint pupils and slowed neurologic func-
tion. A dose of naloxone (a narcotic antago-
nist used to treat acute intoxications)
administered intramuscularly caused no
improvement. The patient was transferred by
helicopter to a tertiary medical center.
Upon arrival at the PICU, the child
underwent a computerized tomography scan
of the head, which was negative, and a suc-
tion of gastric contents, revealing no pharma-
cologic or toxicologic substances. The child
was given a second dose of naloxone, again
without effect. Physical exam was remarkable
primarily for decreased responsiveness to
pain, reduced deep tendon reflexes, small 
(2-mm) pupils with sluggish response to
light, and purposeless speech. An EKG
revealed occasional, spontaneously resolving
sinus bradycardia. A urine toxicology screen
was negative. After a 5-day hospital stay with
only supportive treatment, the child was dis-
charged home on no medications, with a
diagnosis of poisoning by unspeciﬁed drug or
medicine. Eighteen months later, when this
child’s home was evaluated for methyl
parathion contamination, all surface wipe
samples showed levels indicating the need for
remediation. The child’s urine PNP level
was nondetectable.
Case 3. During a period of a year and a
half of almost monthly spraying in her home,
a 43-year-old female went to the ED on ﬁve
different occasions. The primary complaint
during three visits was coughing, wheezing,
headache, and sore throat. She had no fever
or abnormal vital signs during any of these
visits. Her physical exams were always unre-
markable, and she was diagnosed as having
viral upper respiratory infection. During two
additional visits, the primary complaint was
nausea and vomiting. At the last visit she pre-
sented with a 2-day history of fever
(101.9°F), nausea, vomiting, diarrhea, and an
episode of fainting. Her physical exam was
within normal limits and a pregnancy test was
negative. During our investigation 1 year
later, this woman had a urinary PNP level of
830 ppb.
Discussion
Illegal indoor application of methyl
parathion in Lorain County, Ohio, had been
going on for several years before coming to
the attention of public health authorities.
Once the contamination became known,
many different local, state, and federal agen-
cies became involved in evaluating and clean-
ing up the contaminated homes. As reported
in this article, the CDC worked with local
public health ofﬁcials to try to determine the
extent of human exposure and adverse health
outcomes associated with this indoor misuse
of a pesticide. Our overall findings showed
widespread and prolonged exposure to
methyl parathion among the Lorain County
study population. Younger children appeared
to be at greatest risk of exposure. Health care
providers apparently did not consider pesti-
cide poisoning when confronted with acute
generic presentations, and although veteri-
narians may have diagnosed pesticide poison-
ing in pets, this information did not reach
the public health system. Our study results
suggest that acute and short-term organo-
phosphate poisoning occurred but was not
recognized in Lorain County during the
years that methyl parathion was sprayed in
private residences.
Acute organophosphate poisoning may
follow oral, dermal, or inhalation exposure to
methyl parathion (11). After hepatic con-
version, paraoxon (a more toxic form of
parathion) is transported to the cholinergic
nerve junction, where it inhibits acetyl-
cholinesterase, resulting in accumulation of
acetylcholine at the synapses. The effect is an
initial stimulation, followed by paralysis of
cholinergic transmission. Classic symptoms of
acute poisoning can be divided into mus-
carinic (parasympathetic), nicotinic (sympa-
thetic and motor), and central nervous system
manifestations (12). Muscarinic signs and
symptoms include chest tightness; dyspnea;
increased bronchial secretions; increased
sweating, salivation, and tearing; bradycardia
and decreased blood pressure; nausea, vomit-
ing, and diarrhea; miosis; and urinary inconti-
nence. Nicotinic effects include muscular
twitching, weakness, tachycardia, and
increased blood pressure. Central nervous sys-
tem manifestations include anxiety, restless-
ness, insomnia, headache, depression,
confusion, slurred speech, and generalized
weakness. Some researchers suggest that dis-
turbances in thermoregulation may lead to
elevated body temperature after exposure to
anticholinesterase agents (13). Medical stu-
dents are often taught to associate organo-
phosphate poisoning with the acronym
SLUDGE—salivation, lacrimation, urination,
defecation, gastrointestinal distress, and emesis
(14). Unfortunately these are all fairly generic
symptoms that would not prompt an emer-
gency caregiver to consider organophosphate
poisoning unless the medical history suggested
exposure (15).
Misdiagnosis of organophosphate poison-
ing may be more likely among children than
adults because children are perceived as less
likely to be exposed and because children
may present with a less traditional array of
signs and symptoms (16). In a retrospective
review of 37 pediatric cases of confirmed
organophosphate poisoning diagnosed at a
tertiary care center in Dallas, Texas, 20 of 24
transferred patients were misdiagnosed by
the referring hospital (17). This is similar to
the finding in our case review; none of the
ED health care providers even considered
pesticide poisoning in their diagnostic rule
outs. As in the Zwiener and Ginsberg study
(17), the Lorain children did not exhibit
many of the classic signs and symptoms such
as bradycardia, muscle fasciculation, and
meiosis that are frequently observed in
adults. It is possible that many of these chil-
dren were exposed dermally, compared with
the oral route of exposure that results in a
more classic poisoning presentation. Dermal
exposure may lead to more systemic manifes-
tations such as bradycardia and diarrhea.
However, even if a child does present with
the cardinal signs of increased secretions, it is
possible to confuse increased lacrimation
with tears of distress, as in our second case
example. Similarly, interpretation of
increased salivation and incontinence is difﬁ-
cult in a child who wears diapers and is in
the process of teething. It is also possible that
children are more physiologically sensitive to
pesticides compared with adults (18), as sug-
gested by an investigation of indoor exposure
to methyl parathion in a Mississippi home.
While two adults remained symptom-free,
seven siblings were hospitalized, and one
child died (3).
The children in our study population also
appeared to have a greater opportunity for
acute and prolonged exposure than did other
household members. The survey revealed that
young children had disproportionately higher
median PNP levels compared with other
household members and that 12 of the 21
people who ﬁt the criteria of potentially poi-
soned were children younger than 3 years of
age. Children were logically at greater risk of
physical contact with sprayed surfaces because
very young children are more likely to spend
time in their homes, and the most consis-
tently sprayed areas were baseboards that
crawling children could routinely contact.
Our ﬁnding that animals may have been
missed sentinels of residential organophos-
phate exposure has potential public health
implications. Veterinarians are more likely to
diagnose and treat organophosphate poison-
ing because household pets are frequently
intentionally exposed to this class of chemicals
as part of external parasite control programs.
The availability and affordability of over-the-
counter as well as veterinary-supplied insecti-
cides and pesticides means that pet owners
have easy access to these products. When an
animal becomes ill shortly after a pesticide
application, that exposure is often captured in
the history supplied to the veterinarian. An
established method for timely communication
between veterinarians and public health ofﬁ-
cials may have brought methyl parathion mis-
use in Lorain County to the attention of
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actually occurred. The animal deaths that we
and other researchers (17) have documented
should be considered sentinels for potential
human exposure.
Our follow-up study was limited by our
inability to obtain pretreatment blood sam-
ples to evaluate reduced cholinesterase activ-
ity. Erythrocyte and serum cholinesterase
activity assays are considered essential as bio-
markers of effect for organophosphate poi-
soning. Given the retrospective review of
medical records, we could not collect biolog-
ical samples that would be representative of
the poisoning incident. Another area of
uncertainty in our study is the separation
between the date of spraying and the onset
of symptoms. When methyl parathion is
applied outdoors, it degrades quickly (1).
However, during the health survey in
Lorain, we learned that methyl parathion
sprayed indoors behaves very differently
from the product that is applied to crops in
fields. Homes that had been sprayed more
than a year previously continued to exhibit
surface wipe samples positive for methyl
parathion or PNP (4). Similarly, as reported
in this article, we found evidence of ongoing
human exposure with elevated PNP levels in
residents whose homes had been sprayed
years previously.
Our data-gathering techniques and criteria
for our case series probably underestimate the
extent of morbidity resulting from the spray-
ing. We actively followed up hospitalizations
and deaths; we did not review medical records
of participants who sought outpatient care.
Our exclusion of cases where infectious
processes were present ignores the possibility
that infection may have occurred secondarily
to the bronchorrhea that can result from
organophosphate poisoning. Similarly, our
exclusion of cases with psychiatric diagnoses
may have missed subtle poisonings that can
manifest as anxiety (19).
Organophosphate poisonings are almost
certainly underrecognized and underreported
in the United States, and this may be espe-
cially true in semiurban settings like Lorain
County that do not have agricultural or other
obvious occupational sources of exposure. Use
of unlicensed applicators increases the risk of
exposure to pesticides that are not formulated
or registered for indoor use (17). Our investi-
gation reinforces the importance of communi-
cation among all health care professionals in a
community. If an ED physician had consid-
ered organophosphate poisoning for any of
the 21 people we identiﬁed as potentially poi-
soned, or if a veterinarian or animal owner
had reported the ﬁnding of organophosphate
poisoning among indoor pets, it is possible
that the contamination in Lorain County
would not have reached a size and scope that
required Superfund intervention.
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